Loading...

Table of Content

    15 October 2026, Volume 29 Issue 29
    Commentary
    Status and Suggestions on Standardization Construction of Artificial Intelligence-enabled Disease Prevention and Control
    CHEN Cheng, CHEN Kaiyuan, SUN Nailing, ZENG Huatang, LEI Suwen, LIANG Wannian
    2026, 29(29):  4193-4199.  DOI: 10.12114/j.issn.1007-9572.2026.0094
    Asbtract ( )   HTML ( )   PDF (1351KB) ( )  
    Figures and Tables | References | Related Articles | Metrics

    This study aims to analyze the current status and problems of standardization construction for AI-enabled disease prevention and control in China, to provide scientific support for the deep integration of artificial intelligence (AI) and disease prevention and control, and for regulating standardization construction in this field. By analyzing the current status of standardization organizations and standard supply for AI-enabled disease prevention and control in China, and systematically analyzing 334 standards from four dimensions including standard hierarchy, industry chain, business segments, and integrated technical content, we identify problems including fragmented organizational systems, insufficient cross-domain collaboration, and a shortage of integrated standards. In view of the above-mentioned problems, development suggestions are put forward from four perspectives: establishing a regular collaboration mechanism for cross-field standardization technical committees, constructing an integrated standard system framework, filling standard gaps in key areas, and strengthening interdisciplinary talent team building. This study aims to provide theoretical references and practical pathways for the standardization of AI-enabled disease prevention and control, and boost the high-quality development of the disease control sector.

    Hot Topic Research
    Digital Technologies in the Management of Sarcopenia among Older Adults in Asia: a Scoping Review
    CHEN Yujing, WANG Yan, LI Guang, DONG Benchao, YANG Peichuan, MA Jianxiong
    2026, 29(29):  4200-4210.  DOI: 10.12114/j.issn.1007-9572.2025.0506
    Asbtract ( )   HTML ( )   PDF (1499KB) ( )  
    Figures and Tables | References | Related Articles | Metrics

    Sarcopenia in older adults is characterized by the core features of skeletal muscle mass loss, decreased muscle strength, and decline in physical function. It severely impacts activities of daily living and increases the risk of falls, disability, and mortality. With the accelerating aging of the global population, the clinical management of sarcopenia has become increasingly urgent. Traditional intervention methods are limited by issues such as uneven distribution of resources, low adherence, and insufficient personalization, making it difficult to meet the needs of large-scale elderly populations. In recent years, digital technologies have demonstrated significant potential in sarcopenia management due to their precision, convenience, and interactive advantages, becoming a focus of research. To conduct a scoping review of studies on the application of digital technologies in the management of sarcopenia among older adults in Asian regions. Clinical research on digital technologies in sarcopenia interventions for older adults included mobile applications, virtual reality, mixed reality, and artificial intelligence-assisted human pose estimation techniques. The studies were conducted in China, Thailand, and South Korea, with participants being sarcopenia patients aged 60-80 years from community or rural healthcare settings. The intervention duration ranged from 4 to 12 weeks. Applications of digital technologies in this field included recording patient treatment data, developing personalized treatment plans, monitoring treatment processes and outcomes, and evaluating therapeutic effects. In existing studies conducted in Asian regions, compared with traditional therapies, the application and implementation of digital technologies in sarcopenia interventions for older adults can improve patients' muscle mass, muscle strength, and physical function. Some studies suggest that digital technologies also provide certain benefits for patients' quality of life and activities of daily living. However, the clinical application of digital technologies in sarcopenia interventions in this region remains exploratory. Future research requires longer-term, larger-scale clinical trials to further validate their effectiveness and generalizability.

    Research Progress and Challenges of Cognitive Digital Therapeutics in the Intervention of Mild Cognitive Impairment
    MU Hongyu, LI Qianqian, LIU Lu, SUN Xinru, ZHANG Jiaqi, DUAN Yeqing, LI Bin
    2026, 29(29):  4211-4216.  DOI: 10.12114/j.issn.1007-9572.2026.0023
    Asbtract ( )   HTML ( )   PDF (1317KB) ( )  
    References | Related Articles | Metrics

    Mild cognitive impairment (MCI) is a critical transitional stage preceding dementia. With limited pharmacological options available, scalable non-pharmacological interventions are urgently needed. Cognitive digital therapeutics (CDT) represents an emerging approach for cognitive training and long-term management in individuals with MCI. This review summarizes clinical studies of CDT in MCI, synthesizing training modalities, delivery platforms, and their effects on cognitive outcomes. This review also summarizes neuroimaging evidence and highlights potential mechanisms whereby CDT may act through promoting structural brain plasticity and reorganization of functional networks. Building on these findings, this review discusses key challenges in current CDT research, including the lack of adherence assessment, short follow-up durations, and substantial heterogeneity of intervention protocols, and highlights the potential role of artificial intelligence in personalized adaptation, supervised feedback, and remote assessment. Overall, CDT may offer value for long-term MCI management, but longer follow-up studies and standardized adherence-related outcomes are needed to better inform clinical practice and future study design.

    General Practice/Community Health Service·Focus on Family Doctor Contracted Services
    Consistency between Expressed and Perceived Needs for Family Doctor Contracted Services among Rural Older Adults: a Survey of 456 Residents in Ningxia
    HUANG Jiating, LIU Lingna, NING Yanhua, SHI Jing, LI Xinjin, YANG Cailing, YAO Jing
    2026, 29(29):  4217-4225.  DOI: 10.12114/j.issn.1007-9572.2025.0383
    Asbtract ( )   HTML ( )   PDF (1579KB) ( )  
    Figures and Tables | References | Related Articles | Metrics
    Background

    The family doctor contract service for elderly people in rural areas faces issues such as a generally poor patient experience and a lack of perceived benefits, as well as phenomena such as "signing up but not fulfilling the contract" and "failure to renew the contract". The underlying causes of these issues require further investigation.

    Objective

    To investigate the status and influencing factors of consistency between expressed and perceived needs for family doctor contracted services among rural older adults in Ningxia Hui Autonomous Region of China.

    Methods

    A cross-sectional study was conducted from July to September 2024. Stratified cluster sampling was applied to find participants. In the 5 prefecture-level cities of the Ningxia Hui Autonomous Region, 2 counties were selected from each city by convenience sampling method, and 1 administrative village was selected from each county. Two counties were selected from each of the five cities in Ningxia, and one village was chosen from each of the counties. A total of 456 rural older people from the 10 villages were invited into the survey. Socio-demographic information and expressed and perceived needs for family doctor contract services were collected using a self-designed questionnaire. Multiple stepwise regression analysis was used to identify influencing factors, while a random forest model was employed to rank the importance of these factors.

    Results

    The average score for consistency between expressed and perceived needs for family doctor contract services among rural older adults was (11.6±5.3), indicating an overall low level of consistency. The expressed need for basic public health service items (such as establishing health records) was as high as 96.1% (438/456), the perceived need reached 96.7% (441/456), and the satisfaction rate also reached 92.9% (424/456), all of which were at a high level. In contrast, only 5.3% (24/456) of rural older adults expressed a need for special health services (such as home-based care services), 40.1% (183/456) perceived the need, and the satisfaction rate was as low as 5.0% (23/456), all indicating low levels. The results of multiple stepwise linear regression analysis showed that the consistency between expressed and perceived needs for family doctor contract services among rural older adults was affected by multiple factors, including satisfaction with contracted service items, personal health attention, chronic disease status, economic burden, medical treatment experience in primary medical and health institutions in the past year, and smoking habits (P<0.05). Among these factors, satisfaction with contracted service items was the most significant predictor of the consistency of the two needs.

    Conclusion

    The consistency between expressed and perceived needs for individual health services in the family doctor contract among rural older adults remains low, influenced by both subjective factors and objective factors, such as chronic conditions, satisfaction with services, and awareness of self-health. Therefore, the author suggests designing and providing family doctor contract service packages in a way that is tailored to local contexts, especially focusing on service items that address individual perceived needs. The improvement of consistency between expressed and perceived needs will better meet the diverse health management needs of the rural elderly.

    Application of Home-based Medication Therapy Management in Contracted Patients with Diabetes and Hypertension: a Randomized Controlled Trial
    WANG Dunjian, CHEN Yonggang, HU Bing, ZHAO Hengyi, YANG Qing
    2026, 29(29):  4226-4231.  DOI: 10.12114/j.issn.1007-9572.2025.0495
    Asbtract ( )   HTML ( )   PDF (1423KB) ( )  
    Figures and Tables | References | Related Articles | Metrics
    Background

    With the acceleration of urbanization and aging, chronic diseases such as hypertension combined with diabetes bear a heavy burden, while community management faces challenges like unsystematic medication management and poor patient compliance, and existing medication therapy management (MTM) practices rely on large hospitals, are limited to in-hospital settings and lack standard paradigms suitable for primary care, so it is urgent to build a standardized and easy-to-implement home-based MTM service model.

    Objective

    To develop a home-based pharmaceutical care model adapted for primary care settings based on MTM principles, and to evaluate its implementation feasibility and preliminary clinical effects among community-dwelling patients with hypertension and diabetes comorbidity.

    Methods

    A prospective randomized-controlled study was conducted. A total of 168 contracted patients with comorbid hypertension and diabetes were recruited from March to April 2024 from a community health center in Xuzhou. Among them, 18 patients were excluded for failing to meet the inclusion criteria, and 6 were excluded due to refusal to participate or inability to complete follow-up. Finally, 144 patients were included in the study. The patients were randomly assigned in a 1∶1 ratio to an intervention group (n=72) or a control group (n=72) using a computer-generated random sequence. The intervention group received a 6-month home-based MTM pharmaceutical care intervention, including comprehensive medication assessment and reconciliation, multidisciplinary collaborative intervention, and standardized monitoring and follow-up using simple tools (paper logbooks, WeChat groups). The control group received routine follow-up management for 6 months. Differences in medication adherence, disease control rates, safety, and direct medical costs were compared. Feasibility indicators such as recruitment rate and intervention completion rate were also assessed.

    Results

    After the intervention, the medication adherence score in the intervention group was higher than that in the control group (P<0.05); systolic blood pressure, diastolic blood pressure, and HbA1c levels were lower than those in the control group (P<0.05); and the control rates of blood pressure and HbA1c were higher than those in the control group (P<0.05). There was no statistically significant difference in the incidence of adverse drug reactions (ADR) between the two groups (P>0.05). The per capita direct medical cost in the intervention group was lower than that in the control group (P<0.05). The recruitment rate was 85.7% (144/168), the intervention completion rate was 94.4% (68/72), and the service acceptability score was (4.3±0.7).

    Conclusion

    The home-based MTM pharmaceutical care model developed in this study was generally feasible and well accepted in primary care settings, and showed potential in improving medication adherence, disease control, and medication safety. Its clear workflow and simple tools provide a referable pathway for standardized pharmaceutical care for chronic diseases in primary care.

    Development of Preference Attributes and Levels of Family Doctor Contract Services for Patients with Comorbidity of Hypertension and Type 2 Diabetes Mellitus Based on Discrete Choice Experiments
    WANG Lin, CAO Chenchen, HUANG Yichong, LIU Jing
    2026, 29(29):  4232-4240.  DOI: 10.12114/j.issn.1007-9572.2025.0357
    Asbtract ( )   HTML ( )   PDF (1663KB) ( )  
    Figures and Tables | References | Related Articles | Metrics
    Background

    Contracted family doctor service is the main way of community prevention and treatment of hypertension and type 2 diabetes. With the continuous development of the concept and practice of "patient-centered" medical and health services, accurate allocation of service attributes and levels based on patient preferences has become a key path to improve service accessibility, compliance and health outcomes.

    Objective

    This study takes the research on the preference choices of patients with comorbidity of hypertension and type 2 diabetes mellitus (HTN-T2DM) for family doctor contract services as an example, detailing the entire process of attribute and level development, providing a reference and guidance for the development of attributes and levels in discrete choice experiments (DCE), and offering a reference for formulating strategies for family doctor contract services for patients with HTN-T2DM.

    Methods

    Under the guidance of the consolidated framework for implementation research (CFIR), a literature review and policy analysis were conducted to extract and collate potential attributes and construct an attribute pool, semi-structured interviews were carried out with 5 family doctors, 3 institutional principals, and 20 patients with HTN-T2DM from primary-health-care institution in Haikou city to specify the attributes and levels. Finally, 50 HTN-T2DM patients were recruited by convenience sampling to participate in a pretest to verify the rationality of the attributes and levels.

    Results

    Through a literature review, 23 literatures were combed, among which 15 were in Chinese and 8 in English, and 18 attributes were collated. In combination with semi-structured interviews, 8 attributes and corresponding levels were determined. Through the pre-experiment, 7 attributes and levels were ultimately determined, namely, the nature of the institution (government-run/social-run/individual-run), service content (health consultation and guidance/traditional Chinese medicine for preventive treatment of diseases/personalized examination items), service mode (institutional visit/remote diagnosis and treatment/home visit service), self-payment cost (50/100/200 yuan per month), doctor's professional title (junior/intermediate/senior), implementation environment (with priority referral/without priority referral), and medication guidance (2 weeks/1 month/2 months).

    Conclusion

    Scientifically determining attributes and their levels is a crucial foundation for ensuring the effectiveness of DCE. Under the guidance of the CFIR, this study develops 7 attributes and corresponding levels for the preference of family doctor contract services for patients with HTN-T2DM, providing a reference for advancing research on the preference of family doctor contract services for HTN-T2DM patients. Empirical research can be carried out based on these findings in the future to promote the improvement of family doctor contract service strategies.

    Article
    Effect of Acupuncture Combined with Tirofiban on Early Neurological Deterioration in Patients with Ischemic Stroke after Thrombolysis: a Randomized Controlled Trial
    ZHAN Daowei, WEI Xuwang, HU Minlei, XU Yingmei, YANG Xibing, LUO Kaitao
    2026, 29(29):  4241-4247.  DOI: 10.12114/j.issn.1007-9572.2025.0556
    Asbtract ( )   HTML ( )   PDF (1537KB) ( )  
    Figures and Tables | References | Related Articles | Metrics
    Background

    The prevalence of acute ischemic stroke (AIS) remains high, and early neurological deterioration (END) can occur following thrombolytic therapy; however, effective clinical prevention and treatment strategies are currently lacking. Therefore, to explore the efficacy, safety, and potential mechanisms of acupuncture combined with tirofiban in the treatment of END after thrombolysis for AIS holds significant clinical importance.

    Objective

    To evaluate the efficacy and safety of acupuncture combined with tirofiban in the treatment of END following thrombolysis for AIS.

    Methods

    Seventy-six subjects were patients with END who received intravenous thrombolysis for AIS and were hospitalized in the Neurology Department, Jiaxing Hospital of Traditional Chinese Medicine Affiliated to Zhejiang University of Traditional Chinese Medicine from December 2021 to June 2024. They were randomized into a combined group and a control group via the random number table method, with 38 cases in each group. The control group received micro-pump infusion of tirofiban for 72 hours, sequential medication and rehabilitation therapy. The combined group received acupuncture treatment in addition to the control group, using both scalp acupuncture and body acupuncture. Both groups underwent treatment for 2 weeks. Compare the changes in high-sensitivity C-reactive protein (hs-CRP) levels between the two groups before treatment and at 3 and 14 days after treatment. The National Institutes of Health Stroke Scale (NIHSS), Modified Rankin Scale (mRS), Modified Barthel Index (MBI), and Traditional Chinese Medicine (TCM) Symptom Scale were used to assess neurological deficits, activities of daily living, long-term functional independence prognosis, and changes in TCM symptoms in both groups of patients before treatment, 14 days after treatment, and at the 90-day follow-up. At the same time, adverse reactions of two group patients were recorded during the treatment period.

    Results

    During the study period, 2 cases dropped out in the combined group, and 36 cases were completed; 1 case dropped out in the control group, and 37 cases were completed. There was an interaction between group and time for NIHSS, mRS, and TCM Symptom Scale scores (Pinteraction<0.05), and time had a significant main effect on NIHSS, mRS, and TCM Symptom Scale scores (Ptime<0.01). After 14 days post-treatment, the NIHSS, mRS, and TCM Symptom Scale scores were all lower in both groups compared to baseline (P<0.05). After 14 days post-treatment, the NIHSS and TCM Symptom Scale scores were lower in the combined group than in the control group (P<0.05). At the 90 days post-treatment, the NIHSS, mRS, and TCM Symptom Scale scores in both groups were lower than those before treatment (P<0.05); at the 90 days post-treatment, the NIHSS, mRS, and TCM Symptom Scale scores in the combined group were lower than those in the control group (P<0.05). At 14 days and 90 days post-treatment, the MBI scores in both groups were higher than before treatment (P<0.05); at the 90 days post-treatment, the MBI score in the combined group was higher than that in the control group (P<0.05). At 3 days and 14 days post-treatment, the serum hs-CRP levels of both groups decreased compared with those before treatment. There was an interaction between group and time on hs-CRP levels (Pinteraction<0.01), and the main effect of time on hs-CRP levels was significant (Ptime<0.01). The levels in the combined group were lower than those in the control group (P<0.05). A total of 5 cases of adverse reactions occurred in the two groups of patients, with 2 cases in the combined group and 3 cases in the control group.

    Conclusion

    The acupuncture combined with tirofiban treatment can effectively improve END symptoms after thrombolysis in AIS, protect neurological function, and enhance patients' ability to live independently. This may be related to the reduction of inflammatory responses, thereby promoting overall patient recovery.

    Development and Validation of a Risk Prediction Model for Poor Prognosis in Alzheimer's Disease Patients with Community-acquired Pneumonia
    LI Jiao, ZHOU Jianjie, PENG Lang, MEI Yingbing, TAN Zihu
    2026, 29(29):  4248-4257.  DOI: 10.12114/j.issn.1007-9572.2025.0331
    Asbtract ( )   HTML ( )   PDF (2014KB) ( )  
    Figures and Tables | References | Related Articles | Metrics
    Background

    As China enters an aging society, the incidence of Alzheimer's disease (AD) is increasing annually. Concurrently, these patients are susceptible to developing community-acquired pneumonia (CAP), a complication that ultimately leads to adverse outcomes. Therefore, establishing an accurate risk prediction model can assist healthcare professionals in early identification and intervention for high-risk patients, thereby alleviating familial and societal burdens.

    Objective

    To develop a predictive model for the risk of adverse prognosis in AD patients with CAP, analyze the high-risk factors for poor outcomes in this patient population, and provide a basis for formulating targeted treatment measures.

    Methods

    Data retrieval was conducted using the dementia database platform established by Hubei Provincial Hospital of Traditional Chinese Medicine. Hospitalized patients diagnosed with AD and CAP from January 2020 to August 2025 were included as study subjects (n=371). Data collected included demographic and baseline characteristics, comorbidities and behavioral risk factors, assessment scales, and laboratory indicators. The data were randomly split into a training set (n=259) and a validation set (n=112) in a 7∶3 ratio. Subsequently, least absolute shrinkage and selection operator (LASSO) regression with 10-fold cross-validation was employed to screen for optimal predictors. Define the composite outcome of patient death or respiratory failure during hospitalization as an adverse event. Following this screening process, Logistic regression was used to develop the final prediction model, and a nomogram was constructed based on this model. The model performance was evaluated using multiple metrics, including the area under the receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA).

    Results

    The incidence of adverse outcomes in AD patients with CAP was 27.76% (103/371). Using LASSO regression, four potential predictors were selected from 20 candidate variables: CDR score, CURB-65 score, ADL score, and dysphagia. Subsequent multivariate Logistic regression analysis confirmed that these four factors were independent influencing factors for adverse outcomes (P<0.05), with the following odds ratios: CDR score (OR=2.304, 95%CI=1.486-3.572), CURB-65 score (OR=2.263, 95%CI=1.477-3.468), ADL score (OR=2.337, 95%CI=1.033-5.287), and dysphagia (OR=2.042, 95%CI=1.036-4.023). A clinical prediction model (nomogram) was constructed based on these four predictive variables. The area under the ROC curve for the prediction model was 0.835 (95%CI=0.777-0.892) in the training set and 0.902 (95%CI=0.835-0.968) in the validation set, indicating good discriminative ability. The Hosmer-Lemeshow test results showed χ2=7.046 (P=0.531) for the training set and χ2=7.781 (P=0.455) for the validation set, suggesting good model fit. The Brier scores for the calibration curves were 0.137 and 0.108 for the two datasets, further indicating good consistency between predicted and actual values. DCA results showed that using the nomogram model to predict the risk of adverse outcomes provides clinical benefit when the threshold probability ranges from 0.10 to 0.75.

    Conclusion

    The nomogram model developed in this study effectively predicts the risk of adverse outcomes in AD patients with CAP. This tool facilitates early identification of high-risk populations by clinicians, thereby enabling the formulation of individualized interventions to improve patient prognosis.

    Comprehensive Evaluation of ALK Inhibitors in the First-line Treatment of Patients with ALK-positive Non-small Cell Lung Cancer
    YE Ziqi, ZHOU Yujun, LIU Liu, ZHANG Yanfang, HONG Yun, RAO Yuefeng
    2026, 29(29):  4258-4264.  DOI: 10.12114/j.issn.1007-9572.2025.0201
    Asbtract ( )   HTML ( )   PDF (1665KB) ( )  
    Figures and Tables | References | Related Articles | Metrics
    Background

    Currently, six ALK inhibitors (including crizotinib, alectinib, ceritinib, brigatinib, ensartinib, and lorlatinib) have been approved for first-line treatment of ALK-positive advanced non-small cell lung cancer (NSCLC), yet clinical decision-making remains challenging.

    Objective

    This study aimed to comprehensively evaluate these six ALK inhibitors across five dimensions (safety, efficacy, pharmaceutical properties, drug economy, and other properties) to provide evidence-based support for clinical drug selection.

    Methods

    Data were sourced from drug labels, guidelines by the National Comprehensive Cancer Network (NCCN), Chinese Society of Clinical Oncology (CSCO), and European Society for Medical Oncology (ESMO), network meta-analyses, as well as authoritative platforms including Zhejiang Provincial Two-Designated Healthcare Security Information Database, the National Healthcare Security Administration Information Database, and the National Medical Products Administration Drug Evaluation Center, covering information essential for evaluating drug efficacy, safety, and pricing. Based on the Rapid Guideline for Drug Evaluation and Selection in Chinese Medical Institutions (2nd Edition), a comprehensive evaluation system comprising five dimensions (safety, efficacy, pharmaceutical properties, drug economy, and other properties) was developed using the Delphi method to assess six ALK inhibitors (including crizotinib, alectinib, ceritinib, brigatinib, ensartinib, and lorlatinib). A nine-member expert panel with senior titles and over five years of relevant experience conducted six discussion rounds to finalize evaluation criteria (three rounds to define items and three to assign weights). Final scoring and statistical analysis were performed independently by a two-author team according to the established standards.

    Results

    The overall ranking of the six ALK inhibitors was: brigatinib (85.5 points) >alectinib (82.7 points) >lorlatinib (82.2 points) >ensartinib (78.8 points) >ceritinib (77.4 points) >crizotinib (76.5 points). Alectinib scored highest in the core dimensions (safety, efficacy, and pharmaceutical properties) (71.0 points). Generational trend analysis revealed that second-generation inhibitors outperformed third-generation and first-generation drugs (except for ceritinib and ensartinib), while in core dimensions, third-generation inhibitors scored higher than second-generation and first-generation drugs (except for alectinib and ceritinib).

    Conclusion

    This study demonstrates that different ALK inhibitors exhibit distinct advantages across the five evaluated dimensions. Brigatinib achieved the highest overall score, while alectinib ranked highest in core dimensions. Second- and third-generation drugs generally performed better, providing valuable evidence for individualized treatment selection based on clinical needs.

    The Value of Platelet-to-lymphocyte Ratio and Uric Acid in Early Differentiation of Spinal Tuberculosis from Brucellar Spondylitis
    WANG Lei, DU Zhicai, YU Haiyang, ZHAO Zeyu
    2026, 29(29):  4265-4271.  DOI: 10.12114/j.issn.1007-9572.2024.0648
    Asbtract ( )   HTML ( )   PDF (1760KB) ( )  
    Figures and Tables | References | Related Articles | Metrics
    Background

    The elderly population has a relatively high proportion in spinal tuberculosis (STB) and brucellosis spondylitis (BS), especially in those with underlying diseases and low income. Traditional methods are inadequate for early differentiation between the two diseases. Serological tests and PCR are costly, while bacterial culture is time-consuming. Therefore, exploring laboratory diagnostic indicators for these two diseases under the influence of underlying diseases holds important clinical significance.

    Objective

    To investigate the value of common laboratory indicators[platelet-to-lymphocyte ratio (PLR) and uric acid (UA) ] in distinguishing STB from BS.

    Methods

    A total of 232 patients diagnosed with STB and BS at the Second Affiliated Hospital of Inner Mongolia Medical University from January 1, 2015 to October 31, 2024 were included in this study. Patients were divided into STB group (132 cases) and BS group (100 cases), and further categorized into groups with and without underlying diseases (132 cases without underlying diseases and 100 cases with underlying diseases). Laboratory indicators, including complete blood count, biochemical parameters, and inflammatory markers, were collected and compared between groups. Multivariate Logistic regression analysis was conducted to identify clinically meaningful predictive markers and construct a predictive model. The model fit was evaluated via Hosmer-Lemeshow goodness-of-fit test. The sensitivity and specificity of the model were evaluated using the receiver operating characteristic (ROC) curve, and the area under the curve (AUC) was used to assess its predictive value. The differences in AUC values among the ROC curves of various indicators were compared via DeLong test.

    Results

    Multivariate Logistic regression analysis revealed that PLR (OR=0.993, 95%CI=0.990-0.997) and UA (OR=0.994, 95%CI=0.991-0.997) were independent influencing factors in distinguishing STB from BS (P<0.05). The Hosmer-Lemeshow test results indicated that the model fit was good (χ2=3.721, P=0.881). The AUC for diagnosing STB and BS using PLR was 0.649, with an optimal cutoff value of 162.14, sensitivity of 59.1% and specificity of 64.0%. The AUC for diagnosing STB and BS using UA was 0.669, with an optimal cutoff value of 383.75 μmol/L, sensitivity of 34.8%, and specificity of 93.0%. The AUC for diagnosing STB and BS using the combination of PLR and UA was 0.721, with an optimal probability cutoff value of 0.489, sensitivity of 69.7% and specificity of 66.0%. Result of Delong test showed that the AUC value of the combined diagnosis of PLR and UA was higher than that of PLR alone, with a statistically significant difference (Z=2.167, P=0.030). However, the difference between the combined diagnosis and UA alone was not statistically significant (Z=1.884, P=0.065).

    Conclusion

    PLR and UA can serve as reference indicators for the early-stage differential diagnosis between STB and BS. The combined diagnostic efficacy of the two biomarkers outperforms standalone PLR. They are applicable to early screening and differentiation among elderly patients and possess prominent clinical application value.

    Significance of Elevated Levels of Leukocyte Immunoglobulin-like Receptor B1, CD36, and Lymphatic Enhancer Factor 1 in Patients with Myeloma
    ZHANG Tianyu, CHEN Fei, LI Xin, ZHANG Jiajia, SHEN Man, ZHAN Xiaokai, TANG Ran, FAN Sibin, ZHAO Fengyi, HUANG Zhongxia
    2026, 29(29):  4272-4280.  DOI: 10.12114/j.issn.1007-9572.2025.0219
    Asbtract ( )   HTML ( )   PDF (2112KB) ( )  
    Figures and Tables | References | Related Articles | Metrics
    Background

    Multiple myeloma (MM) is an incurable malignant plasma cell tumor characterized by clonal proliferation of plasma cells in the bone marrow, accompanied by CRAB symptoms such as elevated blood calcium (C), renal damage (R), anemia (A), and bone damage (B). Human leukocyte immunoglobulin like receptor B1 (LILRB1) and CD36 are associated with metabolic abnormalities and immune evasion. Lymphatic enhancer factor 1 (LEF-1) is closely related to tumorigenesis, disease progression, and drug resistance. Optical genome mapping (OGM) technology can comprehensively reflect the cytogenetic changes of patients.

    Objective

    To explore the relationship between changes of LILRB1, CD36 and LEF-1 in the tumor microenvironment and the onset of MM.

    Methods

    76 MM patients who were hospitalized in the Department of Hematology and Oncology, Beijing Chao-yang Hospital, Capital Medical University from December 2023 to January 2025 were selected. They were divided into active MM (aMM group, n=43) and reactive MM (rMM group, n=33) based on their disease status. Meanwhile, 24 healthy individuals who underwent physical examinations at the hospital during the same period and were matched in terms of gender and age were selected as the plasma detection control group (HC group), and 23 patients with benign anemia were selected as the bone marrow plasma detection control group. Enzyme-linked immunosorbent assay (ELISA) was used to detect the levels of LILRB1, CD36, and LEF-1 in plasma and bone marrow plasma. Receiver operating characteristic (ROC) curves for plasma and bone marrow plasma LILRB1, CD36, and LEF-1 in diagnosing MM were plotted, and patients were divided into high-expression and low-expression groups based on the cut-off value. Follow-up was conducted for the patients until March 2025, and the progression-free survival (PFS) and overall survival (OS) were recorded. OGM was used to detect cytogenetic abnormalities in 6 MM patients.

    Results

    In the plasma, the levels of LILRB1 and LEF-1 in the aMM group were higher than those in the HC group and the rMM group (P<0.05); in the bone marrow plasma, the levels of LILRB1 and LEF-1 in the aMM group were higher than those in the benign anemia group and the rMM group (P<0.05). In the plasma, the level of CD36 in the aMM group was higher than that in the HC group and the rMM group (P<0.05). Correlation analysis showed that in plasma, LEF-1 was positively correlated with LILRB1 (rs=0.403, P=0.007) and CD36 (rs=0.340, P=0.017), and LILRB1 was positively correlated with CD36 (rs=0.406, P=0.006). In bone marrow plasma, LEF-1 was positively correlated with LILRB1 (rs=0.528, P=0.001), and LILRB1 was positively correlated with CD36 (rs=0.343, P=0.037), whereas no correlation was observed between LEF-1 and CD36 (rs=0.080, P=0.612). Survival analysis revealed that in plasma, patients with high expression of LILRB1, CD36, and LEF-1 had significantly shorter PFS and OS compared to those with low expression (P<0.05). In bone marrow plasma, patients with high LILRB1 expression had shorter OS, and those with high LEF-1 expression had shorter PFS and OS (P<0.05). OGM testing showed that 3 out of 6 MM patients (50%) had 17q12 (HNF1β) deletion, accompanied by abnormalities such as del (17p), t (4; 14), and high expression of LEF-1. The median PFS and OS were 14 months and 41 months, respectively.

    Conclusion

    The high expression of LILRB1, CD36 and LEF-1 is associated with disease activity, progression, and poor prognosis in MM. LILRB1 and CD36 may participate in the pathological process of MM through lipid metabolism regulation and immune suppression. OGM testing on 6 MM patients revealed that 50% of them had 17q12 deletion, leading to abnormal expression of HNF1β, an upstream regulatory gene of LEF-1, which activates the Wnt signaling pathway to promote MM development. Therefore, LILRB1, CD36, and LEF-1 are expected to serve as biomarkers and potential therapeutic targets for evaluating MM activity, predicting disease progression, and providing new ideas for MM treatment.

    Automatic Segmentation of Colorectal Cancer Lesions in Abdominal CT Images Using a Deep Learning Network Based on Fused 3D U-Net and Transformer: a Multicenter and Multidevice Study
    HUANG Mu, ZHANG Daochun, YANG Wei, ZHONG Liming, YUAN Wenjing, JIA Ziqi, TAN Xiangliang, DUAN Xiaohui, LIU Xian, CHEN Weicui
    2026, 29(29):  4281-4287.  DOI: 10.12114/j.issn.1007-9572.2025.0130
    Asbtract ( )   HTML ( )   PDF (1935KB) ( )  
    Figures and Tables | References | Related Articles | Metrics
    Background

    The application of deep learning in medical imaging faces challenges such as time-consuming and labor-intensive data annotation, which hinders their clinical translation efficiency.

    Objective

    To investigate the feasibility and efficacy of a deep learning network (TransUNet-Cascade) that integrates 3D U-Net and Transformer for the automatic segmentation of colorectal cancer (CRC) lesions in abdominal CT images.

    Methods

    A retrospective analysis was conducted on contrast-enhanced abdominal CT images from 2 180 CRC patients at Guangdong Provincial Traditional Chinese Medicine Hospital (Center 1), Nanfang Hospital, Southern Medical University (Center 2), and Sun Yat-sen Memorial Hospital, Sun Yat-sen University (Center 3) between January 2018 and May 2023. The dataset was divided into a training set (n=1 159), a validation set (n=289), and an external test set (n=732) using weighted random sampling. A cascaded network framework (TransUNet-Cascade) based on 3D U-Net and Swin Transformer was proposed, optimizing segmentation accuracy through a multi-stage learning strategy. Model performance was evaluated using manual annotations as the gold standard, with metrics including Dice similarity coefficient (DSC), F1 score, 95% Hausdorff distance (HD95), intersection over union (IoU), precision (PRE), and recall rate (REC). This study selected the 3D no new U-Net (3D nnU-Net) as the baseline model for comparison. Under the same dataset and evaluation criteria, a systematic training and performance comparison was conducted with the proposed TransUNet-Cascade network to comprehensively verify its effectiveness in the CRC segmentation task.

    Results

    In the external test set, the performance of the two deep learning models based on the AP CT images was superior to that based on the VP CT images. TransUNet-Cascade achieved average DSC, F1 score, HD95, IoU, PRE, and REC values of 0.740, 0.839, 34.084, 0.656, 0.737, and 0.767, respectively, which were overall superior to 3D nnU-Net (average DSC, F1 score, HD95, IoU, PRE, and REC values of 0.724, 0.838, 35.954, 0.642, 0.730, and 0.744, respectively). The model demonstrated the best segmentation performance for right-sided colon cancer (DSC=0.784), while segmentation of rectal cancer was relatively less effective (DSC=0.622).

    Conclusion

    By combining the strengths of convolutional neural networks and Transformers, TransUNet-Cascade improves the accuracy of automatic CRC lesion segmentation, demonstrating potential for clinical application.

    Inhibition Effect of Hydrogen Water on Cisplatin Induced Hepatocyte Injury via Upregulating NFE2L2/HMOX1 Expression
    WANG Han, CHEN Jianhua, SONG Shili, HAO Zhen, HUO Zhongchao, LI Sha, LI Weixia
    2026, 29(29):  4288-4294.  DOI: 10.12114/j.issn.1007-9572.2024.0093
    Asbtract ( )   HTML ( )   PDF (2308KB) ( )  
    Figures and Tables | References | Related Articles | Metrics
    Background

    Cisplatin induced drug-induced liver injury is a common toxic side effects in tumor chemotherapy, which seriously disturbs the clinical treatment of patients. Hydrogen, as a selective antioxidant, has good adjunctive therapeutic effects in various injury related diseases, but its preventive effect and mechanism in cisplatin induced liver injury are not clear.

    Objective

    To study the protective effect and mechanism of hydrogen water on oxidative stress injury of hepatocytes induced by cisplatin.

    Methods

    From June 2022 to June 2023, human normal liver cell line WRL68 were divided into control group, cisplatin group, hydrogen water group, and hydrogen water plus cisplatin group. Control group was cultured with RPMI-1640 medium containing 10% fetal bovine serum for 48 h. Cisplatin group was cultured with RPMI-1640 medium containing 10% fetal bovine serum for 24 h, then added 3 mg/L cisplatin and continued culturing for 24 h. Hydrogen water group was cultured with 0.6 mg/L hydrogen water medium for 48 h. Hydrogen water plus cisplatin group was cultured with 0.6 mg/L hydrogen water medium for 24 h, then added 3 mg/L cisplatin and continued culturing for 24 h. Then collect cells of each gorup, and hepatocyte activity was detected with CCK-8 method. Cell apoptosis was detected by flow cytometry. Mitochondrial membrane potential (MMP) was detected via Rhodamine 123 fluorescence staining method, and intracellular reactive oxygen species (ROS) levels were detected via DCFH-DA fluorescence probe staining method, the proteins and mRNA expression of nuclear factor erythroid 2-related factor 2 (NFE2L2) and heme oxygenase-1 (HMOX1) were detected by western blotting and RT-qPCR.

    Results

    Compared with the control group, the apoptosis rate and ROS level of cisplatin group increased (P<0.05), while the relative levels of MMP, NFE2L2, HMOX1 protein and mRNA decreased (P<0.05). There was no statistically significant difference in cell apoptosis rate and ROS level between hydrogen water group and control group (P>0.05), while the relative levels of MMP, NFE2L2, and HMOX1 proteins and mRNA increased (P<0.05). Compared with cisplatin group, hydrogen water plus cisplatin group decreased in cell apoptosis rate and ROS level (P<0.05), while the relative levels of MMP, NFE2L2, HMOX1 proteins and mRNA increased (P<0.05).

    Conclusion

    Hydrogen water can inhibit the oxidative stress injury in cisplatin induced hepatocytes via activating NFE2L2/HMOX1 signaling pathway, and improving MMP, then alleviate drug-induced liver injury.

    Article·Research of Specific Population
    Gestational Weight Gain and Energy Management: Composition, Relationship Exploration and Future Perspectives
    SHU Xinyu, YAO Mi, JUAN Juan, LI Chenglong, KANG Xin, YANG Huixia
    2026, 29(29):  4295-4302.  DOI: 10.12114/j.issn.1007-9572.2025.0324
    Asbtract ( )   HTML ( )   PDF (1947KB) ( )  
    Figures and Tables | References | Related Articles | Metrics

    Gestational weight gain is a key indicator for assessing the nutritional status of pregnant women and evaluating the fetal development. Maintaining appropriate weight gain during pregnancy is fundamental to achieving favorable pregnancy outcomes and long-term prognosis. This article analyzes the components of gestational weight gain, provides an overview of weight gain recommendations for different groups of pregnant women, explores the relationship between gestational weight gain and energy intake, and subsequently offers actionable solutions for the future clinical management and research.

    Construction of Grading Management Index System for Gestational Hyperglycemia Patients Based on Triangle Hierarchical Management Model
    LI Xiaoyun, DAI Meifen, CAI Shu
    2026, 29(29):  4303-4309.  DOI: 10.12114/j.issn.1007-9572.2025.0443
    Asbtract ( )   HTML ( )   PDF (1914KB) ( )  
    Figures and Tables | References | Related Articles | Metrics
    Background

    With the encouragement of the three-child policy in China, the change in dietary patterns, and the popularization of early screening for metabolic diseases in pregnancy, the incidence of hyperglycemia in pregnancy has been increasing year by year, bringing a heavy medical burden to pregnant women and their offspring, as well as to the family and society, and the effective management of patients with hyperglycemia in pregnancy is of great clinical significance.

    Objective

    To construct the index system of grading management for patients with gestational hyperglycemia, improve the efficiency of clinical work, and provide theoretical basis for the management of patients with gestational hyperglycemia.

    Methods

    Through literature search and group discussion, the index system of hierarchical management was initially formulated. 15 experts were interviewed twice by Delphi method in February 2025, and the indexes were screened according to the indexes and the feedbacks of experts, determined the evaluation index system and used analytic hierarchy process to calculate the weight.

    Results

    The recovery rates of the two rounds of expert inquiry were 100%, the authority coefficients were 0.772 and 0.850, and the Kendall coordination coefficients were 0.319 and 0.344, respectively (P<0.05). Hierarchical analysis yielded importance scores of 4.40 to 4.93 and 4.67 to 4.93 for primary and secondary indicators, respectively. Finally, the grading management index system of gestational hyperglycemia patients was determined, which included 3 first-level indexes, 10 second-level indexes and 28 third-level indexes.

    Conclusion

    The index system for grading and managing patients with hyperglycemia in pregnancy in this study is scientific and reliable. It not only comprehensively assesses the health status of gestational diabetes mellitus patients, but also categorizes and assigns values to specific indexes, which helps clinicians to comprehensively and hierarchically manage their patients, and can provide references to the clinical work of healthcare professionals and improve work efficiency.

    Impact of Thyroid Dysfunction in Twin Pregnancies during the First Trimester on Pregnancy Outcomes: a Comparative Study Based on Different Reference Standards
    YUAN Xianxian, CHEN Tengda, ZHANG Lirui, YAN Xin, ZHENG Wei, LI Guanghui
    2026, 29(29):  4310-4317.  DOI: 10.12114/j.issn.1007-9572.2025.0101
    Asbtract ( )   HTML ( )   PDF (2161KB) ( )  
    Figures and Tables | References | Related Articles | Metrics
    Background

    Thyroid hormones are crucial for metabolism, growth, and development in the human body, especially playing a pivotal role in fetal development during early pregnancy. Currently, research on thyroid hormone reference ranges for twin pregnancies remains inconsistent, and most studies on thyroid dysfunction and pregnancy outcomes in twin pregnancies still use singleton pregnancy reference ranges as a benchmark.

    Objective

    To establish reference intervals for thyroid stimulating hormone (TSH) and free thyroxine (FT4) in early pregnancy among women with twin pregnancies, compare the incidence of thyroid dysfunction diagnosed based on singleton versus twin standards, and compare pregnancy outcomes for different thyroid function statuses under the two standards.

    Methods

    Twin pregnant women who visited Beijing Obstetrics and Gynecology Hospital, Capital Medical University, from October 2015 to February 2021 and met the inclusion and exclusion criteria were enrolled. We used chemiluminescence to detect TSH and FT4 in early pregnancy, and determined the reference range based on bilateral limits of P2.5-P97.5. The reference interval for thyroid function in the first trimester of single pregnancy in our hospital is TSH 0.59-3.54 mU/L and FT4 11.8-18.4 pmol/L, respectively. Thyroid function results in early pregnancy for twin pregnancies were classified using both singleton and twin reference standards, including normal thyroid function, subclinical hypothyroidism, hypothyroidism, subclinical hyperthyroidism, and hyperthyroidism. Given the limited sample size, patients with hypothyroidism and subclinical hypothyroidism were combined into the hypothyroidism group, and those with hyperthyroidism and subclinical hyperthyroidism were combined into the hyperthyroidism group for statistical analysis. Differences in pregnancy outcomes for thyroid dysfunction diagnosed using different reference standards were analyzed. Binary Logistic regression was used to analyze the correlations between first-trimester thyroid function reference standards and gestational diabetes mellitus, hypertensive disorders of pregnancy, as well as preterm birth. Multiple linear regression was applied to assess the associations of first-trimester thyroid function reference standards with gestational weight gain, neonatal birth weight, and neonatal TSH.

    Results

    A total of 1 724 twin pregnant women were enrolled, of which 254 met the inclusion and exclusion criteria for establishing reference intervals for thyroid function in early twin pregnancies. The TSH range for twin pregnancies in early pregnancy was 0.11-3.16 mU/L, and the FT4 range was 12.45-28.56 pmol/L. Using the single reference standard for classification, 2 cases (0.1%) of clinical hypothyroidism were diagnosed, 33 cases (1.9%) of subclinical hypothyroidism, 860 cases (49.9%) of normal, 363 cases (21.1%) of subclinical hyperthyroidism, 366 cases (21.2%) of clinical hyperthyroidism, and 100 cases (5.8%) of other. Using the twin reference standard for classification, 3 cases (0.2%) of clinical hypothyroidism were diagnosed, 47 cases (2.7%) of subclinical hypothyroidism, 1 609 cases (93.3%) of normal, 3 cases (0.2%) of subclinical hyperthyroidism, 3 cases (0.2%) of clinical hyperthyroidism, and 59 cases (3.4%) of other. Using different reference standards for thyroid function in the first trimester of pregnancy for singleton and twin pregnancies, there was a statistically significant difference in the classification of thyroid function in the first trimester of twin pregnancy (P<0.001). Among pregnant women with normal thyroid function, the pre-pregnancy BMI and early pregnancy TSH in the singleton reference standard were higher than those in the twin reference standard, while the early pregnancy FT4 was lower than that in the twin reference standard (P<0.05). Among pregnant women with hypothyroidism, the early pregnancy TSH in the singleton reference standard was higher than that in the twin reference standard (P<0.05). Among pregnant women with hyperthyroidism, the early pregnancy TSH, total weight gain during pregnancy, and neonatal birth weight in the singleton reference standard were higher than those in the twin reference standard, while the early pregnancy FT4 was lower than that in the twin reference standard (P<0.05). The results of regression analysis showed that among pregnant women with hyperthyroidism, different reference standards for thyroid function were associated with gestational weight gain and neonatal birth weight (P<0.05).

    Conclusion

    The TSH reference range for early twin pregnancies at our center is 0.11-3.16 mU/L, and the FT4 reference range is 12.45-28.56 pmol/L. The number of cases of subclinical hyperthyroidism and hyperthyroidism diagnosed using the twin reference standard is significantly lower than that using the single reference standard. In pregnant women with hyperthyroidism, the reference standards for thyroid function are related to weight gain during pregnancy and the birth weight of the newborn.

    Article·Study of Evidence-based Medicine
    Meta-integration of Qualitative Studies on Sexual Life and Intimate Relationship Experience in Patients with Endometriosis
    TU Xulian, XIE Wan, WU Liping, LIU Xia, LI Xiaoyan, LENG Mingyue
    2026, 29(29):  4318-4325.  DOI: 10.12114/j.issn.1007-9572.2024.0639
    Asbtract ( )   HTML ( )   PDF (2159KB) ( )  
    Figures and Tables | References | Related Articles | Metrics
    Background

    Endometriosis is a common gynecological condition in which patients often suffer from painful intercourse and irregular menstruation, leading to reduced quality of sexual life and impaired intimacy. A deeper exploration of the physical, emotional, social, and spiritual dimensions of women's experiences is necessary to provide more effective and comprehensive support for the care of endometriosis patients and their partners.

    Objective

    To systematically evaluate the sexual experience and intimate relationship changes of patients with endometriosis, and to provide reference for formulating intervention measures to improve the sexual life quality of patients with endometriosis.

    Methods

    PubMed, CINAHL, Web of Science, Embase, Cochrane Library, Scopus, PsycINFO, CNKI, Wanfang Data, VIP, and SinoMed were searched for qualitative studies on the sexual experience of patients with endometriosis from database establishment to October 28, 2024. The literature was evaluated using JBI evidence-based Health Care Center qualitative research quality evaluation criteria, and meta-integration method was used to summarize and interpret the research results.

    Results

    A total of 10 literatures were included, 51 themes were extracted, and 10 categories were summarized to form 3 integration results: poor sexual experiences and diverse coping strategies (individualized experience of dyspareunia, silence driven by guilt and fertility-related pregnancy desires, avoidance due to distressing physical and psychological experiences, and positive coping among patients with post-traumatic growth); impacts of sexuality on intimate relationships under disease burden (sexuality serving as a "bridge" sustaining intimate bonds, catastrophic deterioration of intimate relationships in individuals with negative coping styles, and enhanced partner intimacy through joint positive confrontation against illness); unmet multifaceted needs for maintaining healthy sexuality and intimate relationships (the desire for normal and pleasurable sexual experiences, expectations of support and understanding from partners and family members, and demand for professional and effective healthcare-system-based support).

    Conclusion

    Medical workers should pay attention to the painful sexual experience and intimate relationship changes brought by endometriosis patients, pay attention to the positive psychological experience of endometriosis patients and their partners, build a continuous medical support system, guide the establishment of a positive disease coping style, and promote the joint management of the disease by patients and their partners.

    Comparative Effectiveness of GLP-1 Receptor Agonists on Patients with Diabetic Kidney Disease: a Network Meta-analysis
    ZHAO Congjuan, JIN Tiantian, LIANG Jie, WANG Beining, GAO Yan
    2026, 29(29):  4326-4336.  DOI: 10.12114/j.issn.1007-9572.2025.0252
    Asbtract ( )   HTML ( )   PDF (3111KB) ( )  
    Figures and Tables | References | Related Articles | Metrics
    Background

    Diabetic kidney disease is one of the microvascular complications of diabetes mellitus, which significantly impacts the quality of life of patients. Owing to abnormal renal function, the application of traditional hypoglycemic medications is severely restricted. At present, glucagon-like peptide-1 (GLP-1) receptor agonists not only play a role in lowering blood glucose but also exhibit multiple beneficial effects, including renal protection. Nevertheless, considering the numerous types of GLP-1 receptor agonists available, there is a dearth of relevant clinical evidence-based medical data to assess the relative advantages and disadvantages of the therapeutic effects of different GLP-1 receptor agonists.

    Objective

    To systematically assess the therapeutic effects of various GLP-1 receptor agonists on renal function, proteinuria, and glycemic control in patients with diabetic kidney disease.

    Methods

    A comprehensive literature search was conducted across multiple electronic databases, including PubMed, Embase, Cochrane Library, Web of Science, CNKI, Wanfang Data Knowledge Service Platform, VIP Database, and Sinomed. The search strategy combined both subject headings and free-text terms, with retrieval limited to the period from database inception up to March 16, 2025. Randomized controlled trials evaluating the use of various GLP-1 receptor agonists in the treatment of diabetic kidney disease were included. In the experimental groups, patients received GLP-1 receptor agonist therapy, whereas control groups were administered either another GLP-1 receptor agonist or standard conventional treatment. Network meta-analysis and graphical visualization were performed using Stata 16.0 software. The relative efficacy rankings of different GLP-1 receptor agonists across outcome measures were assessed using the surface under the cumulative ranking curve (SUCRA) analysis.

    Results

    A total of 27 studies involving 7 019 patients were included, encompassing seven GLP-1 receptor agonists: exenatide, dulaglutide, semaglutide, liraglutide, polyethylene glycol lovenatide, benaglutide, and albiglutide. The results of the network meta-analysis indicated that, the estimated glomerular filtration rate (eGFR) levels of patients treated with exenatide (WMD=10.21, 95%CI=3.09-17.34), polyethylene glycol lovenatide (WMD=9.76, 95%CI=1.07-18.46), and liraglutide (WMD=7.13, 95%CI=2.79-11.47) were significantly higher than those of conventional standard therapy (P<0.05). The serum creatinine (Scr) levels of patients treated with semaglutide (WMD=-24.03, 95%CI=-47.72 to -0.33), exenatide (WMD=-17.55, 95%CI=-32.68 to -2.42), and liraglutide (WMD=-10.92, 95%CI=-19.05 to -2.80) were significantly lower than those of conventional standard therapy (P<0.05). Exenatide was also associated with a lower UACR level compared to traditional standard treatment (WMD=-192.45, 95%CI=-353.07 to -31.83; P<0.05). Regarding UAER reduction, dulaglutide (WMD=-228.51, 95%CI=-282.19 to -174.83), exenatide (WMD=-159.67, 95%CI=-295.06 to -24.28), liraglutide (WMD=-34.24, 95%CI=-47.58 to -20.90), and benaglutide (WMD=-16.68, 95%CI=-32.05 to -1.30) showed significantly greater reductions than the control (P<0.05). Furthermore, dulaglutide exhibited a significantly lower UAER level than liraglutide (WMD=-194.27, 95%CI=-249.58 to -138.96; P<0.05), and both dulaglutide (WMD=-211.83, 95%CI=-267.67 to -156.00) and exenatide (WMD=-142.99, 95%CI=-279.26 to -6.73) outperformed benaglutide (P<0.05). Duraglutide (WMD=-2.44, 95%CI=-4.05 to -0.83), semaglutide (WMD=-2.00, 95%CI=-3.80 to -0.20), and liraglutide (WMD=-0.93, 95%CI=-1.64 to -0.22) were associated with significantly lower FPG levels compared to conventional standard therapy (P<0.05). Additionally, dulaglutide demonstrated a lower FPG level than albiglutide(WMD=-2.34, 95%CI=-4.58 to -0.10; P<0.05). Compared with conventional standard therapy, polyethylene glycol lovenatide (WMD=-1.22, 95%CI=-2.09 to -0.35), semaglutide (WMD=-0.81, 95%CI=-1.41 to -0.21), and liraglutide (WMD=-0.60, 95%CI=-0.87 to -0.34) showed significantly better glycemic control (P<0.05). According to SUCRA rankings, exenatide ranked highest in delaying the decline of eGFR and reducing UACR. Semaglutide ranked first in reducing Scr, dulaglutide in reducing UAER and FPG, and pegylated lovenatide in HbA1c reduction.

    Conclusion

    A network meta-analysis was conducted to compare the efficacy of seven GLP-1 receptor agonists, and it was found that dulaglutide may be the best choice in reducing urinary albumin excretion rate and controlling fasting blood glucose. There was no significant difference in the improvement of renal function among different GLP-1 receptor agonists. In the future, more high-quality randomized controlled trials with larger sample sizes and more comprehensive types of drugs are needed to verify the results.

    Article·Research Methodology
    Development of the Traditional Chinese Medicine Health Behaviors Stage-specific Influencing Factors Scale and Its Reliability and Validity Testing
    WANG Sixue, YUAN Yue, XIONG Lisha, ZHOU Chunyi, YUAN Xiangqing, FANG Xuelian, ZHANG Ailin, WANG Yuncui
    2026, 29(29):  4337-4344.  DOI: 10.12114/j.issn.1007-9572.2025.0278
    Asbtract ( )   HTML ( )   PDF (2248KB) ( )  
    Figures and Tables | References | Related Articles | Metrics
    Background

    Practicing Traditional Chinese Medicine (TCM) health behaviors is crucial for improving individual and overall community health. However, the practice rate remains suboptimal. Identifying stage-related influencing factors of TCM health behaviors is a prerequisite for formulating targeted strategies, yet no specific tool has been developed to explore such factors among residents.

    Objective

    To develop the TCM Health Behaviors Stage-specific Influencing Factors Scale and test its reliability and validity, providing an assessment tool for identifying facilitators and barriers to TCM health behaviors.

    Methods

    Guided by the theoretical domains framework and multi-theory model of health behavior change, an initial item pool was constructed through literature review and qualitative interviews. A trial version of the scale was developed after Delphi expert consultation and pre-survey. From October 2024 to December 2024, convenience sampling was conducted in Hubei, Sichuan and Guangdong provinces. 597 questionnaires were distributed, 547 valid questionnaires were recovered, with a validity rate of 91.62%, and the scale entries were screened and tested for scale reliability and validity.

    Results

    An initial scale with 3 dimensions and 28 items was preliminarily constructed through literature review and semi-structured qualitative interviews. The scale was modified and improved through expert consultation. The enthusiasm of experts in both rounds was 100.0%. The expert authority coefficients were 0.889 and 0.903, respectively, and the Kendall coordination coefficients were 0.151 and 0.114, respectively (P<0.05). Combined with the experts' opinions and the results of group discussions, the scale was modified, forming a test scale with 3 dimensions and 26 items. After reliability and validity tests, the TCM Health Behaviors Stage-specific Influencing Factors Scales included 3 dimensions and 10 items. Exploratory factors showed that the cumulative variance contribution rate of the 3 factors was 63.231%, and the load values of each item were between 0.605 and 0.834. For the confirmatory factor analysis model fit indices, the ratio of chi-square value to degrees of freedom (χ2/df) =2.012, the root mean square error of approximation (RMSEA) =0.061, the root mean square residual (RMR) =0.032, the goodness-of-fit index (GFI) =0.956, the normed fit index (NFI) =0.919, the incremental fit index (IFI) =0.957, and the Tucker-Lewis index (TLI) =0.939, suggesting a good model fit. The convergent validity and discriminant validity indices were within acceptable ranges. The content validity of the TCM Health Behaviors Stage-specific Influencing Factors Scales level was 0.970, and the content validity indices at each item level were between 0.890 and 1.000. The overall Cronbach's α coefficient of the TCM Health Behaviors Stage-specific Influencing Factors Scales was 0.818, and the split-half reliability was 0.778, indicating good reliability.

    Conclusion

    The scale for measuring stage-related influencing factors of TCM health behaviors exhibits good reliability and validity, serving as a practical measurement tool for health managers to study influencing factors of TCM health behaviors.

    Determination of Primary and Minor Symptoms of Common Syndromes in Sepsis Based on Clinical Investigation Combined with Expert Questionnaires
    CHUN Liu, LEI Siyuan, FENG Zhenzhen, ZHAO Hulei, LI Jiansheng
    2026, 29(29):  4345-4352.  DOI: 10.12114/j.issn.1007-9572.2024.0603
    Asbtract ( )   HTML ( )   PDF (2262KB) ( )  
    Figures and Tables | References | Related Articles | Metrics
    Background

    Sepsis is the leading cause of death and critical illness worldwide, and Traditional Chinese Medicine has certain advantages in preventing and treating sepsis. On the premise of clarifying the common symptoms of sepsis, further establishing its primary and secondary symptoms can provide a basis for the establishment of diagnostic criteria for sepsis symptoms.

    Objective

    To explore the primary and minor symptoms of common syndromes in sepsis combining clinical investigations and expert questionnaires providing a basis for the establishment of diagnostic criteria for Traditional Chinese Medicine syndromes in sepsis.

    Methods

    Collect 1 082 sepsis patients admitted to the intensive care units (ICUs) of 8 hospitals, including the First Affiliated Hospital of Henan University of Chinese Medicine, the First Affiliated Hospital of Zhengzhou University, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Henan Provincial People's Hospital, the First People's Hospital of Zhengzhou, Hainan Traditional Chinese Medicine Hospital, Chinese Medicine Hospital of Puyang, and the First Affiliated Hospital of Guangzhou University of Chinese Medicine. Collected the clinical data and established a database from May 2021 to August 2022. Using descriptive statistics, Logistic regression, and artificial neural networks to analyze the symptoms of common sepsis syndromes and determine the primary and minor symptoms. Based on clinical investigation, an expert questionnaire survey was conducted using the Delphi method to further determine the primary and minor symptoms of common syndromes.

    Results

    Based on clinical investigations and expert questionnaires, combined with the results of statistical analysis, data mining and the Delphi method, in accordance with the principles for determining primary and secondary symptoms of common syndromes, and considering clinical practice, the primary and secondary symptoms of common syndromes of sepsis were finalized after group discussion. The main symptoms of phlegm heat obstructing the lungs were cough, excessive phlegm, yellow sputum color, etc., the minor symptoms were fever, thirst, chest tightness, etc. The main symptoms of intense exuberant heat toxin syndrome were high fever, irritability, and shortness of breath, etc., while the minor symptoms included delirium, red tongue, and burnt yellow fur, etc. The main symptoms of Yangming fu-organ excess syndrome included delirium, abdominal pain, and fullness of the epigastric region, etc., while the minor symptoms included hot flashes, thirst, and irritability, etc. The main symptoms of blood stasis and toxin obstruction (damage) syndromes were purple and dark nails, blue and purple lips, dark red or purple tongue, etc., while the minor symptoms were delirium, high fever, chest and rib pain, etc. The main symptoms of lung Qi deficiency syndrome are cough, thin phlegm, and white phlegm color, etc., while the minor symptoms were fatigue, weakness, and spontaneous sweating, etc. The main symptoms of Yin deficiency and internal heat syndrome were dry cough, dry throat, irritability, etc., while the minor symptoms were wheezing, thirst, dry mouth, etc. The main symptoms of Qi and blood deficiency syndrome were fatigue, weakness, dizziness, etc., while the minor symptoms were mental lethargy, drowsiness, lack of Qi, and laziness, etc. The main symptoms of Yin exhaustion and Yang deficiency syndrome were dizziness, restlessness, and shortness of breath, etc., while the minor symptoms were mouth opening, shoulder lifting, drowsiness, and red tongue, etc.

    Conclusion

    This study clarifies the primary and minor symptoms of eight common syndromes in sepsis, including phlegm heat obstructing the lungs syndrome, intense exuberant heat toxin syndrome, Yangming fu-organ excess syndrome, blood stasis and toxin obstruction (damage) syndrome, lung Qi deficiency syndrome, Yin deficiency and internal heat syndrome, Qi and blood deficiency syndrome, and Yin exhaustion and Yang deficiency syndrome. These can provide a basis for establishing diagnostic criteria for these syndromes.